Stay updated on Lomvastomig in Solid Tumors Dose Escalation Clinical Trial
Sign up to get notified when there's something new on the Lomvastomig in Solid Tumors Dose Escalation Clinical Trial page.

Latest updates to the Lomvastomig in Solid Tumors Dose Escalation Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoChange DetectedThe page's revision marker was updated to v3.6.4, replacing the previous v3.6.3.SummaryDifference0.1%

- Check17 days agoNo Change Detected
- Check24 days agoNo Change Detected
- Check31 days agoChange DetectedAdded revision v3.6.3 to the history and removed revision v3.6.2, indicating a small update to the page's release notes.SummaryDifference0.1%

- Check38 days agoChange DetectedFooter now shows Revision: v3.6.2 instead of v3.6.0, indicating a recent site update. This reflects a platform/UI version bump rather than any modification to trial data or history content.SummaryDifference0.1%

- Check53 days agoChange DetectedThe latest version updates the recruitment status to indicate no further participant enrollment and updates the record to Revision: v3.6.0, replacing the previous v3.5.5 entry.SummaryDifference0.2%

- Check60 days agoChange DetectedThe page revision label changed from v3.5.4 to v3.5.5. This indicates a new release of the page version without altering the study content or history data.SummaryDifference0.1%

- Check81 days agoChange DetectedRevision: v3.5.4 has been added and Revision: v3.5.3 has been removed. This updates the page's revision history to reflect the latest version rather than altering trial data or public content.SummaryDifference0.1%

Stay in the know with updates to Lomvastomig in Solid Tumors Dose Escalation Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Lomvastomig in Solid Tumors Dose Escalation Clinical Trial page.